• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Baerveldt 250平方毫米青光眼植入物的临床经验。

Clinical experience with the Baerveldt 250-mm2 Glaucoma Implant.

作者信息

WuDunn Darrell, Phan Anh-Danh T, Cantor Louis B, Lind John T, Cortes Arnold, Wu Bin

机构信息

Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.

出版信息

Ophthalmology. 2006 May;113(5):766-72. doi: 10.1016/j.ophtha.2006.01.049.

DOI:10.1016/j.ophtha.2006.01.049
PMID:16650671
Abstract

PURPOSE

To report the intermediate-term results of the Baerveldt 250-mm2 Glaucoma Implant for treatment of adult glaucoma.

DESIGN

Retrospective, noncomparative, interventional case series.

PARTICIPANTS

One hundred eight adult patients (108 eyes) with glaucoma who received a Baerveldt 250-mm2 Glaucoma Implant.

INTERVENTION

Implantation of the Baerveldt 250-mm2 Glaucoma Implant.

MAIN OUTCOME MEASURES

Intraocular pressure (IOP), visual acuity, number of glaucoma medications, and surgical complications. Success was defined as IOP > or = 6 mmHg and < or = 21 mmHg (with or without antiglaucoma medications), without further glaucoma surgery, devastating complication, or loss of light perception attributable to drainage implantation.

RESULTS

Mean age was 63.8+/-16.5 years. Mean postoperative follow-up was 22.8 months (range, 0.2-84.9; interquartile range, 3.9-36.3). Mean preoperative IOP was 36.3+/-13.0 mmHg, on 2.9+/-1.1 antiglaucoma medications. The mean postoperative IOP at final visit was 15.8+/-7.6 mmHg (P<0.0001, paired t test), on 0.8+/-1.0 antiglaucoma medications (P<0.0001, Wilcoxon test). Kaplan-Meier success rates were 0.92 (6 months, n = 81), 0.88 (12 months, n = 75), 0.84 (18 months, n = 68), and 0.79 (24 months, n = 61).

CONCLUSIONS

The Baerveldt 250-mm2 Glaucoma Implant provides good intermediate-term success for the treatment of adult refractory glaucoma.

摘要

目的

报告Baerveldt 250平方毫米青光眼植入物治疗成人青光眼的中期结果。

设计

回顾性、非对比性、介入性病例系列。

参与者

108例接受Baerveldt 250平方毫米青光眼植入物的成年青光眼患者(108只眼)。

干预措施

植入Baerveldt 250平方毫米青光眼植入物。

主要观察指标

眼压(IOP)、视力、青光眼药物使用数量及手术并发症。成功定义为眼压≥6 mmHg且≤21 mmHg(无论是否使用抗青光眼药物),无需进一步青光眼手术、严重并发症或因引流植入导致光感丧失。

结果

平均年龄为63.8±16.5岁。术后平均随访时间为22.8个月(范围0.2 - 84.9个月;四分位间距3.9 - 36.3个月)。术前平均眼压为36.3±13.0 mmHg,使用2.9±1.1种抗青光眼药物。末次随访时术后平均眼压为15.8±7.6 mmHg(配对t检验,P<0.0001),使用0.8±1.0种抗青光眼药物(Wilcoxon检验,P<0.0001)。Kaplan-Meier成功率在6个月时为0.92(n = 81),12个月时为0.88(n = 75),18个月时为0.84(n = 68),24个月时为0.79(n = 61)。

结论

Baerveldt 250平方毫米青光眼植入物治疗成人难治性青光眼中期效果良好。

相似文献

1
Clinical experience with the Baerveldt 250-mm2 Glaucoma Implant.Baerveldt 250平方毫米青光眼植入物的临床经验。
Ophthalmology. 2006 May;113(5):766-72. doi: 10.1016/j.ophtha.2006.01.049.
2
Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant.与Baerveldt 250平方毫米青光眼植入物相比,Ahmed S2青光眼引流阀的疗效。
Ophthalmology. 2008 Jul;115(7):1141-7. doi: 10.1016/j.ophtha.2007.10.034. Epub 2007 Dec 27.
3
Randomized clinical trial of the 350-mm2 versus the 500-mm2 Baerveldt implant: longer term results: is bigger better?350平方毫米与500平方毫米Baerveldt植入物的随机临床试验:长期结果:越大越好吗?
Ophthalmology. 1999 Dec;106(12):2312-8. doi: 10.1016/S0161-6420(99)90532-8.
4
Intermediate-term outcome of Baerveldt glaucoma implants in Asian eyes.亚洲人眼中Baerveldt青光眼植入物的中期结果。
Ophthalmology. 2003 May;110(5):888-94. doi: 10.1016/S0161-6420(03)00088-5.
5
Intraocular pressure control and complications with two-stage insertion of the Baerveldt implant.Baerveldt植入物两阶段植入的眼压控制及并发症
Ophthalmology. 2003 Feb;110(2):353-8. doi: 10.1016/S0161-6420(02)01752-9.
6
Baerveldt glaucoma implant in the management of refractory childhood glaucomas.贝尔维尔德青光眼植入物在难治性儿童青光眼治疗中的应用
Ophthalmology. 2004 Dec;111(12):2204-10. doi: 10.1016/j.ophtha.2004.05.017.
7
The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma II: longer-term outcomes from a single surgeon.用于难治性青光眼的艾哈迈德分流器与贝尔维尔德分流器对比研究II:来自单一外科医生的长期结果
Ophthalmology. 2006 Jun;113(6):913-7. doi: 10.1016/j.ophtha.2006.02.029.
8
Surgical outcomes of combined phacoemulsification and glaucoma drainage implant surgery for Asian patients with refractory glaucoma with cataract.亚洲难治性青光眼合并白内障患者行白内障超声乳化吸除联合青光眼引流植入术的手术效果
Am J Ophthalmol. 2004 Feb;137(2):294-300. doi: 10.1016/j.ajo.2003.08.036.
9
The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a single-surgeon comparison of outcome.用于难治性青光眼的艾哈迈德分流器与贝尔维尔德分流器:单术者的疗效比较
Ophthalmology. 2003 Sep;110(9):1814-21. doi: 10.1016/S0161-6420(03)00574-8.
10
Glaucoma drainage implants in Asian eyes.亚洲人眼中的青光眼引流植入物。
Ophthalmology. 1998 Nov;105(11):2117-22. doi: 10.1016/S0161-6420(98)91136-8.

引用本文的文献

1
Ahmed Glaucoma Valve Implantation in Jordan: Indications and Complications.约旦的艾哈迈德青光眼引流阀植入术:适应证与并发症
Clin Ophthalmol. 2024 Dec 4;18:3581-3590. doi: 10.2147/OPTH.S496586. eCollection 2024.
2
Risk Factors for Failure of Tube Shunt Surgery: A Pooled Data Analysis.管分流术失败的风险因素:汇总数据分析。
Am J Ophthalmol. 2022 Aug;240:217-224. doi: 10.1016/j.ajo.2022.02.027. Epub 2022 Mar 12.
3
Biocompatibility and feasibility of VisiPlate, a novel ultrathin, multichannel glaucoma drainage device.VisiPlate,一种新型超薄多通道青光眼引流装置的生物相容性和可行性。
J Mater Sci Mater Med. 2021 Nov 24;32(12):141. doi: 10.1007/s10856-021-06613-8.
4
Treatment outcomes in the neovascular glaucoma tube versus trabeculectomy study.新生血管性青光眼管 versus 小梁切除术研究的治疗结果。
Graefes Arch Clin Exp Ophthalmol. 2021 Oct;259(10):3067-3076. doi: 10.1007/s00417-021-05257-2. Epub 2021 Jun 14.
5
Conjunctival repair after glaucoma drainage device exposure using collagen-glycosaminoglycane matrices.使用胶原-糖胺聚糖基质修复青光眼引流装置暴露后的结膜
BMC Ophthalmol. 2018 Feb 27;18(1):60. doi: 10.1186/s12886-018-0721-6.
6
Vision Loss and Recovery after Baerveldt Aqueous Tube Shunt Implantation.Baerveldt房水引流管植入术后的视力丧失与恢复
J Ophthalmol. 2017;2017:4140305. doi: 10.1155/2017/4140305. Epub 2017 Jan 18.
7
Neovascular glaucoma: a review.新生血管性青光眼:综述
Int J Retina Vitreous. 2016 Nov 14;2:26. doi: 10.1186/s40942-016-0051-x. eCollection 2016.
8
Surgical Outcome of Ahmed Valve Implantation in Mexican Patients with Neovascular Glaucoma.墨西哥新生血管性青光眼患者艾哈迈德瓣膜植入术的手术结果
J Curr Glaucoma Pract. 2014 Sep-Dec;8(3):86-90. doi: 10.5005/jp-journals-10008-1168. Epub 2015 Jan 15.
9
Long-term Outcomes of Ahmed Glaucoma Valve Implantation in Refractory Glaucoma at Farabi Eye Hospital, Tehran, Iran.伊朗德黑兰法拉比眼科医院难治性青光眼患者接受艾哈迈德青光眼引流阀植入术的长期疗效
Middle East Afr J Ophthalmol. 2016 Jan-Mar;23(1):104-9. doi: 10.4103/0974-9233.164611.
10
Intravitreal bevacizumab and Ahmed glaucoma valve implantation in patients with neovascular glaucoma.玻璃体内注射贝伐单抗与艾哈迈德青光眼引流阀植入术治疗新生血管性青光眼患者
Int J Ophthalmol. 2014 Oct 18;7(5):837-42. doi: 10.3980/j.issn.2222-3959.2014.05.18. eCollection 2014.